Axcella flunks long Covid PhII primary goal — but plots a path into PhIII

Kyle LaHucik

Senior Reporter

As Covid-19 cases mount once again and millions of people experience lingering symptoms months after diagnosis, Axcella Therapeutics wants to treat long Covid, but like …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Axcella flunks long Covid PhII primary goal — but plots a path into PhIII

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Updated: Sage reports Phase 2 failure in Huntington's disease, ends drug's development

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy

Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor

Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship

GSK plots regulatory filings for PBC itch after positive Phase 3 readout

Are programs with compounded GLP-1s safe for your population?

Ax­cel­la flunks long Covid PhII pri­ma­ry goal — but plots a path in­to PhI­II

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Up­dat­ed: Sage re­ports Phase 2 fail­ure in Hunt­ing­ton's dis­ease, ends drug's de­vel­op­ment

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

Pfiz­er taps on­col­o­gy head Boshoff as Dol­sten's chief sci­en­tif­ic of­fi­cer suc­ces­sor

Ex­clu­sive: For­mer Pfiz­er com­mer­cial chief An­gela Hwang to join Flag­ship

GSK plots reg­u­la­to­ry fil­ings for PBC itch af­ter pos­i­tive Phase 3 read­out

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Axcella flunks long Covid PhII primary goal — but plots a path into PhIII

Updated: Sage reports Phase 2 failure in Huntington's disease, ends drug's development

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy

Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor

Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship

GSK plots regulatory filings for PBC itch after positive Phase 3 readout

Are programs with compounded GLP-1s safe for your population?